Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Synthetic Drugs May Pose Hidden Risks in Workplace, Novus Medical Detox Center Cautions Employers
  • USA - English


News provided by

JoTo PR

Oct 24, 2016, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Will Wesch, Director of Admissions for Novus Medical Detox Center, alerts employers of hidden risks with synthetic drugs in the workplace
Will Wesch, Director of Admissions for Novus Medical Detox Center, alerts employers of hidden risks with synthetic drugs in the workplace

New Port Richey, Fla. (PRWEB) October 24, 2016 -- Though many employers have implemented workplace drug policies and drug screening, newer synthetic drugs are not typically detected by routine tests.(1) Roughly half of employers do not screen for synthetic opioids in standard tests,(2) and dozens of new psychoactive substances (NPS) continue to emerge each year.(3) Novus Medical Detox Center, a leading Florida-based drug treatment facility, warns employers to be aware of the threat posed by synthetic drugs and counsels them to take preventive and corrective measures.

Synthetic opioid or NPS use can fly completely under the radar unless employers are actively monitoring for signs of substance abuse and screening for those specific compounds.

Post this

A recent survey found that 4 out of 5 employers observed a drug-related issue with at least one worker. Among the 87% of respondents who conduct drug testing, 91% screen for opiates such as heroin and morphine, but only 52% test for synthetic opioids such as oxycodone, dilaudid and fentanyl.(2) A new government report reveals the true extent of the problem: more than half of all workers have used illicit drugs, and roughly 20% have done so in the past year. In total, nearly 29.7 million full-time and part-time workers admitted to past-year drug use, including 11.8 million who misused prescription pain relievers, tranquilizers, stimulants or sedatives.(4)

Synthetic opioids and other prescription drugs are not the only problem. A United Nations report noted that 644 new synthetic psychoactive substances were documented between 2008 and 2015, including 75 just last year.(3) Many users are drawn to these “designer drugs”—including synthetic cannabinoids (Spice, K2) and synthetic cathinones, or “bath salts” (Flakka, Bloom, Cloud Nine)—specifically because they are not usually detectable in routine drug screens.(1)

“Drug policies and testing have helped organizations make great progress toward minimizing substance abuse in the workforce,” said Will Wesch, Director of Admissions for Novus Medical Detox Center. “However, synthetic drugs have become a growing problem in recent years—one that many employers aren’t even aware exists. Synthetic opioid or NPS use can fly completely under the radar unless employers are actively monitoring for signs of substance abuse and screening for those specific compounds.”

Wesch advises employers to update their drug policies and testing procedures to include these often-overlooked substances. He notes that even legitimately prescribed opioids can have adverse effects on employees’ job performance and safety, and warns that many prescriptions are subsequently diverted and abused. In addition, NPS manufacturers create synthetic versions of controlled substances specifically to avoid existing drug laws, openly selling them online or in drug paraphernalia stores with the implication that they are a “legal” alternative.(1)

“If workplace drug policies do not specifically prohibit or test for synthetic drugs, employees may engage in their use as a way to circumvent the rules,” cautioned Wesch. He previously shared advice for updating drug policies, and urges employers to train staff on how to spot and respond to signs of substance abuse. He also advocates for referral to an employee assistance program (EAP) and drug detox/rehab treatment, pointing to studies that show each dollar spent on EAPs yields $1.49 to $13 in benefits.(5) “Recognizing the issue of synthetic drugs in the workplace is the first step. By taking preventive and corrective actions, employers can improve the health, safety and productivity of those struggling with substance abuse and, ultimately, their workforce as a whole.”

Novus offers medically supervised drug treatment programs designed to minimize the discomfort of withdrawal and promote successful recovery. The Florida drug detox facility employs proven medical protocols, such as 24-hour access to nursing care and withdrawal specialists, and customizes its treatment plans to patient’s individual needs. Novus is acclaimed for its expertise in treating high-dose methadone cases, and is proficient in detoxing patients from other high-dose substances just as safely, comfortably and effectively.

For more information on Novus Medical Detox Center and its alcohol and drug detox programs, visit http://www.novusdetox.com.

About Novus Medical Detox Center:
Novus Medical Detox Center has earned The Joint Commission’s Gold Seal of Approval for Behavioral Health Care Accreditation as an inpatient medical detox facility. Licensed by the Florida Department of Children and Families, Novus provides safe, effective alcohol and drug treatment programs that are based on proven medical protocols and designed to minimize the discomfort of withdrawal. The facility is located on 3.25 acres in New Port Richey, Florida, in a tranquil, spa-like setting bordering protected conservation land. Intent on proving that detox doesn’t have to be painful or degrading, Novus set out to transform the industry by bringing humanity into medical detox with individually customized treatment programs and 24/7 access to nursing care and withdrawal specialists. Today, Novus is renowned as a champion of industry standardization and a staunch advocate of patients fighting to overcome substance use disorders. Frequently recognized for its contributions to the industry and local community, Novus has become a regular source to media publications such as The Wall Street Journal and USA Today, and has ranked in the Tampa Bay Business Journal’s Fast 50, the Florida Business Journal’s Top 500 and the Inc. 5000 list of America’s fastest-growing companies. For more information on Novus’ medically supervised detox programs, visit http://novusdetox.com.

1. Substance Abuse and Mental Health Services Administration. “Spice, Bath Salts, and Behavioral Health”; SAMHSA Advisory; Fall 2014. store.samhsa.gov/shin/content//SMA14-4858/SMA14-4858.pdf

2. National Safety Council and Indiana Attorney General’s Office. Results From a Survey of Indiana Employers; December 7, 2015. nsc.org/NSCDocuments_Advocacy/FINAL%20Media%20briefing%20PPT.PDF

3. United Nations Office on Drugs and Crime. World Drug Report 2016; June 23, 2016; page 56. unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf

4. Substance Abuse and Mental Health Services Administration. 2015 National Survey on Drug Use and Health: Detailed Tables; September 8, 2016; Tables 1.30A, 1.30B and 1.65A. samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.htm

5. Wapner, Roger. “Building a Bridge to the Credibility Gap”; The Journal of Employee Assistance; January 2011. thefreelibrary.com/Building+a+bridge+to+the+credibility+gap%3A+using+client...-a0352492001

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.